In today’s dynamic environment, companies are navigating deal-making and innovation spurred by the vertical integration of AI and a rebounding IPO market. Here are ten global trends poised to define the industry in the coming year. The post 10 Key MedTech Themes for 2026 appeared first on MedCity News.
Speaking at a NAACOS meeting, Deborah McGill of MaineHealth Medical Group said tech tools have been great enablers of change
Los republicanos insisten en que los recortes del presidente Donald Trump a Medicaid buscaban reducir el fraude y poner a trabajar a más adultos beneficiarios del programa. Pero los efectos secundarios pueden incluir menos atención médica para niños enfermos. Algunos hospitales infantiles podrían perder miles de millones de dólares en ingresos una vez que se…
Sleep.ai’s $5.5 million in funding was led by Treasure Coast Ventures and included participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York and Supermoon Capital. The post Sleep.ai Secures $5.5M to Scale Sleep Intelligence Platform appeared first on MedCity News.
I lived for nine years with ALS while navigating a healthcare system that routinely obscured my own medical reality. But I know that pain is only amplified for individuals without medical expertise like mine. The post We Have a Problem: Even Doctors Struggle to Navigate our Healthcare System appeared first on MedCity News.
Omada Health is a respected health tech company but what do customers see it? A flesh and blood and an AI analysis follows. The post What Do Consumers and AI Think Of Omada Health? appeared first on MedCity News.
Family premiums for employer-sponsored health insurance rose 7% this year to reach an average of $25,572 annually, KFF’s 2024 benchmark Employer Health Survey finds. On average, workers contribute $6,296 annually to the cost of family coverage. This marks the second year in a row that premiums are up 7%. Over the past five years—a…More
At the heart of this fight are the patients whose lives quite literally depend on Medicaid. But we are also fighting for the caregivers who show up every day, the children who rely on stability, the families who rally around their loved ones, and all those whose lives are shaped by access to care. The…
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News.
CMS unveiled new details of its new RAPID pathway, which is designed to close the gap between FDA approval and Medicare coverage for breakthrough medical devices. Industry reaction has been largely positive, as medical device companies often sit in “coverage purgatory” for years. The post How CMS Is Tackling ‘Coverage Purgatory’ for Medical Devices appeared…